Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multiple Myeloma
Status:
Recruiting
Trial end date:
2024-04-30
Target enrollment:
Participant gender:
Summary
This study evaluates the effectiveness and safety of PEG-rhG-CSF injection for the
reconstruction of neutrophil cells after autologous hematopoietic stem cell transplantation
in lymphoma/multiple myeloma patients.